CCN1 interlinks integrin and hippo pathway to autoregulate tip cell activity
- Authors
- Park, Myo-Hyeon; Kim, Ae Kyung; Manandhar, Sarala; Oh, Su-Young; Jang, Gun-Hyuk; Kang, Li; Lee, Dong-Won; Hyeon, Do Young; Lee, Sun-Hee; Lee, Hye Eun; Huh, Tae-Lin; Suh, Sang Heon; Hwang, Daehee; Byun, Kyunghee; Park, Hae-Chul; Lee, You Mie
- Issue Date
- 20-Aug-2019
- Publisher
- ELIFE SCIENCES PUBLICATIONS LTD
- Citation
- ELIFE, v.8
- Journal Title
- ELIFE
- Volume
- 8
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/1103
- DOI
- 10.7554/elife.46012
- ISSN
- 2050-084X
- Abstract
- CCN1 (CYR61) stimulates active angiogenesis in various tumours, although the mechanism is largely unknown. Here, we report that CCN1 is a key regulator of endothelial tip cell activity in angiogenesis. Microvessel networks and directional vascular cell migration patterns were deformed in ccn1-knockdown zebrafish embryos. CCN1 activated VEGFR2 and downstream MAPK/PI3K signalling pathways, YAP/TAZ, as well as Rho effector mDia1 to enhance tip cell activity and CCN1 itself. VEGFR2 interacted with integrin alpha v beta 3 through CCN1. Integrin alpha v beta 3 inhibitor repressed tip cell number and sprouting in postnatal retinas from endothelial cell-specific Ccn1 transgenic mice, and allograft tumours in Ccn1 transgenic mice showed hyperactive vascular sprouting. Cancer patients with high CCN1 expression have poor survival outcomes and positive correlation with ITGAV and ITGB3 and high YAP/WWTR1. Thus, our data underscore the positive feedback regulation of tip cells by CCN1 through integrin alpha v beta 3/VEGFR2 and increased YAP/TAZ activity, suggesting a promising therapeutic intervention for pathological angiogenesis.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의예과 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/1103)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.